Shockwave Medical falls amid speculation Boston Scientific talks have broken down

Parradee Kietsirikul

• Shockwave Medical (NASDAQ:SWAV) fell 4.6% amid speculation that talks with Boston Scientific (NYSE:BSX) about a takeover have fallen apart. Boston Scientific rose 3.3%.
• Discussions about a takeover have broken down as a deal price couldn't be agreed upon, according to a Street Insider report on Monday, which cited an unidentified source. Boston Scientific (BSX) was said to have offered $275 a share for Shockwave (SWAV). The companies told the publication that they don't comment on rumors or speculation.
• The latest report comes after Bloomberg last month reported that Boston Scientific (BSX) was said to be considering a takeover of Shockwave (SWAV).
• Executives on Boston Scientific's (BSX) Q1 earnings call late last month repeatedly declined to comment on a recent report about a potential takeover of Shockwave (SWAV).

Comments

[artiest]

275, while price was almost 300, normal that deal didn’t go through. Good news that deal didnt take place, within Bsx , future value of swav would shrimp away…

[smadadet]

I'm glad SWAV didn't give in. The stock will reach $375 within the next year and still has a lot of upside as they are barely penetrating the potential market.

[manoncyber]

275$ that`s laughable,

laughable low of course

[Off His Game]

When the talks started SWAV was likely around $200 - now that its had several pieces of good news (CPT code coming) the stock has rallied to at least $250 before this making $275 not good enough for SWAV management.

[Purewater]

Good!